Department of Pediatrics, Beatrix Children's Hospital, UMC Groningen, CA51, P.O. Box 30001, 9700 RB Groningen, Netherlands.
Vaccine. 2011 Oct 13;29(44):7766-72. doi: 10.1016/j.vaccine.2011.07.110. Epub 2011 Aug 5.
Previous studies have shown, that prebiotics can modulate the immune response in infants at risk for allergy, leading to a lower incidence of atopic dermatitis. Few studies have evaluated the effect of prebiotic carbohydrates alone on the vaccine-specific antibody response as a marker for the development of the immune system in healthy infants not at risk for allergy.
This study evaluates the effect of adding a specific prebiotic mixture of short chain galacto-oligosaccharides (scGOS)/long chain fructo-oligosaccharides (lcFOS) ratio 9:1 and pectin-derived acidic oligosaccharides (pAOS) to formula feeding on the specific immunoglobulin responses to Haemophilus influenza type b (Hib) and tetanus immunization in healthy non-atopic infants during the first year of life.
This substudy has been embedded in a multinational multicenter RCT (n=1130 children) to evaluate the effect of study prebiotics on the incidence of fever episodes during the first year of life. The study prebiotics were administered throughout the first year of life. This is a substudy on the vaccine-specific immunoglobulin responses to Hib and tetanus immunizations. Only data of the Dutch children, 80 in the prebiotics group and 84 in the control group, were used for this substudy. They all followed the national vaccination schedule leading to a homogeneous group. Blood was sampled at 6 and 12 months of age.
Hib immunizations: median values did not differ between groups at the age of 6 and 12 months. At the age of 12 months, 34 out of 37 (91.9%) infants in the prebiotics group and 31 out of 34 infants (91.2%) in the control group had Hib antibody levels >1.0 μg/ml. Tetanus immunizations: median values did not differ between groups at the age of 6 and 12 months and were above the cut-off value of 0.1 IU/ml in all infants in both the prebiotics and the control group.
No effect of prebiotics supplementation on vaccination specific antibody levels was found in children up to the age of 12 months; the vaccine specific antibody levels in infants fed the study prebiotics or a control diet were similar during the first year of life. We hypothesize that this specific prebiotic mixture, which resembles the composition of oligosaccharides in human milk, mainly promotes Th1 and Treg dependent immune responses and induces a down regulation of IgE-mediated allergic responses, while the desired vaccine-specific serum antibody responses remain intact.
先前的研究表明,益生元可以调节有过敏风险的婴儿的免疫反应,从而降低特应性皮炎的发病率。很少有研究评估单独使用益生元碳水化合物作为健康婴儿(无过敏风险)免疫系统发育的标志物对疫苗特异性抗体反应的影响。
本研究评估了在配方喂养中添加特定的短链半乳糖寡糖(scGOS)/长链果糖寡糖(lcFOS)比例为 9:1 的益生元混合物和果胶衍生的酸性低聚糖(pAOS)对健康非过敏婴儿在第一年生命中对乙型流感嗜血杆菌(Hib)和破伤风免疫的特异性免疫球蛋白反应的影响。
这项子研究嵌入了一项多中心多国 RCT 中(n=1130 名儿童),以评估研究性益生元对婴儿第一年发热发作发生率的影响。研究性益生元在第一年的生命中都有使用。这是一项关于 Hib 和破伤风免疫的疫苗特异性免疫球蛋白反应的子研究。只有荷兰儿童的数据(益生元组 80 名,对照组 84 名)用于这项子研究。他们都遵循国家疫苗接种计划,形成了一个同质的群体。在 6 个月和 12 个月时采集血液样本。
Hib 免疫接种:6 个月和 12 个月时,两组的中位数无差异。在 12 个月时,益生元组的 37 名婴儿中有 34 名(91.9%)和对照组的 34 名婴儿中有 31 名(91.2%)Hib 抗体水平>1.0μg/ml。破伤风免疫接种:6 个月和 12 个月时,两组的中位数无差异,且在益生元组和对照组的所有婴儿中,抗体水平均高于 0.1IU/ml 的临界值。
在 12 个月以下的儿童中,补充益生元对疫苗特异性抗体水平没有影响;在生命的第一年,用研究性益生元或对照饮食喂养的婴儿的疫苗特异性抗体水平相似。我们假设,这种特定的益生元混合物与母乳中的寡糖组成相似,主要促进 Th1 和 Treg 依赖的免疫反应,并诱导 IgE 介导的过敏反应下调,而所需的疫苗特异性血清抗体反应保持完整。